Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06019455

The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.

A Prospective Observational Study on the Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.

Status
Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study aims to assess the level of participation of thoracic cancer patients undergoing definitive radiotherapy and chemotherapy ± immunotherapy in their medical processes and the association between the level of participation and patients' side effects, quality of life, and long-term survival. Additionally, this study will rate the level of participation from both the patients' and medical staff's perspectives and will compare the differences in ratings from these two viewpoints, as well as their impact on treatment outcomes.

Conditions

Timeline

Start date
2022-06-01
Primary completion
2027-05-30
Completion
2027-05-30
First posted
2023-08-31
Last updated
2024-12-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06019455. Inclusion in this directory is not an endorsement.

The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy. (NCT06019455) · Clinical Trials Directory